艾伯维  AbbVie www.abbvie.com www.abbvie.com.cn
 雅培（Abbott） 将品牌药业务拆分组建新公司Abbvie的计划。Abbvie将作为一个独立的公司，于2013年1月2日在纽约证券交易所交易，股票符号为ABBV。雅培将保留其医疗设备、诊断、营养品业务，以及专利到期的药物
   

 

AbbVie China 17/F, Chong Hing Financial Center
No.288 West Nangjing Road
Shanghai 200003, China

OFFICE +86 21 62631300
FAX +86 21 53079101
EMAIL abbviechinapa@abbvie.com

AbbVie (NYSE:ABBV) is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott. AbbVie combines the focus and passion of a leading-edge biotech with the expertise and capabilities of a long-established pharmaceutical leader to develop and market advanced therapies that address some of the world’s most complex and serious diseases. In 2013, AbbVie will employ approximately 21,000 people worldwide and markets medicines in more than 170 countries.